{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:10:26Z","timestamp":1740179426835,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,6,13]],"date-time":"2010-06-13T00:00:00Z","timestamp":1276387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00105-009-1915-x","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T11:12:29Z","timestamp":1276254749000},"page":"586-592","source":"Crossref","is-referenced-by-count":3,"title":["Methoden und Mittel zur Pigmentierung und Depigmentierung","Methods and means for pigmentation and depigmentation"],"prefix":"10.1007","volume":"61","author":[{"given":"V.","family":"Hegyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,13]]},"reference":[{"key":"1915_CR1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-4362.1991.tb04362.x","volume":"30","author":"Balina","year":"1991","unstructured":"Balina LM, Graupe K (1991) The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30:893\u2013895","journal-title":"Int J Dermatol"},{"key":"1915_CR2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","volume":"328","author":"Bulengo-Ransby","year":"1993","unstructured":"Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK et al (1993) Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 328:1438\u20131443","journal-title":"N Engl J Med"},{"key":"1915_CR3","first-page":"245","volume":"57","author":"Cristodor","year":"2007","unstructured":"Cristodor PL (2007) Treating vitiligo: new hopes from an old technique. TMJ 57:245\u2013248","journal-title":"TMJ"},{"key":"1915_CR4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1346-8138.2002.tb00324.x","volume":"29","author":"Dogra","year":"2002","unstructured":"Dogra S, Kanwar AJ, Parsad D (2002) Adapalene in the treatment of melasma: a preliminary report. J Dermatol 29:539\u2013540","journal-title":"J Dermatol"},{"key":"1915_CR5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0190-9622(95)90131-0","volume":"32","author":"Falabella","year":"1995","unstructured":"Falabella R, Arrunategui A, Barona MI et al (1995) The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol 32:228\u2013232","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR6","first-page":"443","volume":"22","author":"Garcia","year":"1996","unstructured":"Garcia A, Fulton JE Jr (1996) The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 22:443\u2013447","journal-title":"Dermatol Surg"},{"key":"1915_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"Gawkrodger","year":"2008","unstructured":"Gawkrodger DJ, Ormerod AD, Shaw L et al (2008) Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 159:1051\u20131076","journal-title":"Br J Dermatol"},{"key":"1915_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1993.tb03169.x","volume":"129","author":"Griffiths","year":"1993","unstructured":"Griffiths CE, Finkel LJ, Ditre CM et al (1993) Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 129:415\u2013421","journal-title":"Br J Dermatol"},{"key":"1915_CR9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","volume":"131","author":"Grimes","year":"1995","unstructured":"Grimes PE (1995) Melasma etiologic and therapeutic considerations. Arch Dermatol 131:1453\u20131457","journal-title":"Arch Dermatol"},{"key":"1915_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0190-9622(82)70159-8","volume":"7","author":"Grimes","year":"1982","unstructured":"Grimes PE, Minus HR, Chakrabarti SG et al (1982) Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 7:771\u2013778","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1524-4725.1999.99069.x","volume":"25","author":"Gupta","year":"1999","unstructured":"Gupta S, Jain VK, Saraswat PK (1999) Suction blister epidermal grafting versus punch skin grafting in recalcitrant and stable vitiligo. Dermatol Surg 25:955\u2013958","journal-title":"Dermatol Surg"},{"key":"1915_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1529-8019.2001.014001001.x","volume":"14","author":"Halder","year":"2001","unstructured":"Halder RH, Brooks HL (2001) Medical therapies for vitiligo. Dermatol Ther 14:1\u20136","journal-title":"Dermatol Ther"},{"key":"1915_CR13","first-page":"1","volume":"9","author":"Halder","year":"2004","unstructured":"Halder RM, Richards GM (2004) Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 9:1\u20133","journal-title":"Skin Therapy Lett"},{"key":"1915_CR14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00105-009-1770-9","volume":"60","author":"Hartmann","year":"2009","unstructured":"Hartmann A (2009) Vitiligo. Diagnose, Differenzialdiagnose und aktuelle Therapieempfehlungen. Hautarzt 60:505\u2013515","journal-title":"Hautarzt"},{"key":"1915_CR15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1086\/224980","volume":"76","author":"Henshel","year":"1971","unstructured":"Henshel RL (1971) Ability to alter skin color: some implications for American society. Am J Sociol 76:734\u2013742","journal-title":"Am J Sociol"},{"key":"1915_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0738-081X(03)00048-8","volume":"21","author":"Herane","year":"2003","unstructured":"Herane MI (2003) Vitiligo and leukoderma in children. Clin Dermatol 21:283\u2013295","journal-title":"Clin Dermatol"},{"key":"1915_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000252478","volume":"141","author":"Kandil","year":"1970","unstructured":"Kandil E (1970) Vitiligo-response to 0.2% betamethasone 17valtrate in flexible colloidion. Dermatologica 141:277\u2013281","journal-title":"Dermatologica"},{"key":"1915_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1524-4725.2000.00018.x","volume":"26","author":"Kim","year":"2000","unstructured":"Kim HU, Yun SK (2000) Suction device for epidermal grafting in vitiligo: employing a syringe and a manometer to provide adequate negative pressure. Dermatol Surg 26:702\u2013704","journal-title":"Dermatol Surg"},{"key":"1915_CR19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","volume":"38","author":"Kim","year":"1999","unstructured":"Kim SM, Lee HS, Hann SK (1999) The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol 38:546\u2013550","journal-title":"Int J Dermatol"},{"key":"1915_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archderm.1975.01630130042004","volume":"111","author":"Kligman","year":"1975","unstructured":"Kligman AM, Willis I (1975) A new formula for depigmenting human skin. Arch Dermatol 111:40\u201348","journal-title":"Arch Dermatol"},{"key":"1915_CR21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002660010107","volume":"25","author":"Kunachak","year":"2001","unstructured":"Kunachak S, Leelaudomlipi P, Wongwaisayawan S (2001) Dermabrasion: a curative treatment for melasma. Aesthetic Plast Surg 25:114\u2013117","journal-title":"Aesthetic Plast Surg"},{"key":"1915_CR22","unstructured":"Lamerson C, Nordlund JJ Vitiligo (2000) In: Harper J, Orange A, Prose N (Hrsg) Textbook of pediatric dermatology 2000. Blackwell Science Ltd, London, S 880\u2013889"},{"key":"1915_CR23","first-page":"62","volume":"70","author":"Lasker","year":"1968","unstructured":"Lasker L (1968) A whiteer shade of black. Esquire 70:62\u201365","journal-title":"Esquire"},{"key":"1915_CR24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/abio.2002.5665","volume":"305","author":"Lei","year":"2002","unstructured":"Lei TC, Virador VM, Vieira WD, Hearing VJ (2002) A melanocytekeratinocyte coculture model to assess regulators of pigmentation in vitro. Anal Biochem 305:260\u2013268","journal-title":"Anal Biochem"},{"key":"1915_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","volume":"139","author":"Lepe","year":"2003","unstructured":"Lepe V, Moncada B, Castanedo-Cazares JP et al (2003) A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 139:581\u2013585","journal-title":"Arch Dermatol"},{"key":"1915_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","volume":"25","author":"Lim","year":"1999","unstructured":"Lim JT (1999) Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 25:282\u2013284","journal-title":"Dermatol Surg"},{"key":"1915_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1524-4725.1997.tb00016.x","volume":"23","author":"Lim","year":"1997","unstructured":"Lim JT, Tham SN (1997) Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 23:177\u2013179","journal-title":"Dermatol Surg"},{"key":"1915_CR28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0149-2918(98)80076-3","volume":"20","author":"Lowe","year":"1998","unstructured":"Lowe NJ, Rizk D, Grimes P et al (1998) Azealic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 20:945\u2013959","journal-title":"Clin Ther"},{"key":"1915_CR29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0022-3565(25)12357-4","volume":"276","author":"Maeda","year":"1996","unstructured":"Maeda K, Fukuda M (1996) Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 276:765\u2013769","journal-title":"J Pharmacol Exp Ther"},{"key":"1915_CR30","unstructured":"Masini C, Abeni D Vitiligo (2003) In: Williams H, Bigby M, Diepgen T et al (Hrsg) Evidence-based dermatology, 2nd edn. BMJ Publishing Group, S 545\u2013551"},{"key":"1915_CR31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archderm.135.11.1305","volume":"135","author":"McGovern","year":"1999","unstructured":"McGovern TW, Bolognia J, Leffell DJ (1999) Flip-top pigment transplantation: a novel transplantation procedure for the treatment of depigmentation. Arch Dermatol 135:1305\u20131307","journal-title":"Arch Dermatol"},{"key":"1915_CR32","first-page":"93","volume":"2","author":"Morelli","year":"1997","unstructured":"Morelli JG (1997) Vitiligo in children: treatment options. Dermatol Ther 2:93\u201397","journal-title":"Dermatol Ther"},{"key":"1915_CR33","first-page":"171","volume":"23","author":"Morman","year":"1981","unstructured":"Morman MR (1981) Possible side effects of topical steroids. Am Fam Physician 23:171\u2013174","journal-title":"Am Fam Physician"},{"key":"1915_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","volume":"97","author":"Mosher","year":"1977","unstructured":"Mosher DB, Parrish JA, Fitzpatrick TB (1977) Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol 97:669\u2013679","journal-title":"Br J Dermatol"},{"key":"1915_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0536.1995.tb00832.x","volume":"32","author":"Nakagawa","year":"1995","unstructured":"Nakagawa M, Kawai K, Kawai K (1995) Contact allergy to kojic acid in skin care products. Contact Dermatitis 32:9\u201313","journal-title":"Contact Dermatitis"},{"key":"1915_CR36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-4362.1995.tb03583.x","volume":"34","author":"Nguyen","year":"1995","unstructured":"Nguyen QH, Bui TP (1995) Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol 34:75\u201384","journal-title":"Int J Dermatol"},{"key":"1915_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","volume":"42","author":"Njoo","year":"2000","unstructured":"Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42:245\u2013253","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR38","first-page":"1532","volume":"134","author":"Njoo","year":"1998","unstructured":"Njoo MD, Spuls PI, Bos JD et al (1998) Nonsurgical repigmentation therapies in vitiligo. Metaanalysis of the literature. Arch Dermatol 134:1532\u20131540","journal-title":"Arch Dermatol"},{"key":"1915_CR39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","volume":"42","author":"Njoo","year":"2000","unstructured":"Njoo MD, Vodegel RM, Westerhof W (2000) Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol 42:760\u2013769","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","volume":"2","author":"Njoo","year":"2001","unstructured":"Njoo MD, Westerhof W (2001) Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2:167\u2013181","journal-title":"Am J Clin Dermatol"},{"key":"1915_CR41","first-page":"1543","volume":"134","author":"Njoo","year":"1998","unstructured":"Njoo MD, Westerhof W, Bos JD, Bossuyt PM (1998) A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 134:1543\u20131549","journal-title":"Arch Dermatol"},{"key":"1915_CR42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1524-4725.1999.08248.x","volume":"25","author":"Nouri","year":"1999","unstructured":"Nouri K, Bowes L, Chartier T et al (1999) Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg 25:494\u2013497","journal-title":"Dermatol Surg"},{"key":"1915_CR43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000247517","volume":"184","author":"Orecchia","year":"1992","unstructured":"Orecchia G, Perfetti L (1992) Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 184:120\u2013123","journal-title":"Dermatology"},{"key":"1915_CR44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","volume":"18","author":"Ortel","year":"1988","unstructured":"Ortel B, Tanew A, H\u00f6nigsmann H (1988) Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 18:693\u2013701","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2230.2002.01142.x","volume":"27","author":"Patel","year":"2002","unstructured":"Patel DC, Evans AV, Hawk JL (2002) Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 27:641\u2013644","journal-title":"Clin Exp Dermatol"},{"key":"1915_CR46","unstructured":"Patel MJ (2007) Hyperpigmentation and hypopigmentation. In: Arndt KA, Hsu JTS (Hrsg) Manual of dermatologic therapeutics, 7th edn. Lippincott Williams & Wilkins, S 111\u2013118"},{"key":"1915_CR47","first-page":"324","volume":"76","author":"Pathak","year":"1981","unstructured":"Pathak MA (1981) Treatment of melasma with hydroquinone. J Invest Dermatol 76:324","journal-title":"J Invest Dermatol"},{"key":"1915_CR48","doi-asserted-by":"crossref","unstructured":"Porter J (2000) The psychological effects of vitiligo: response to impaired appearance. In: Hann SK, Nordlund JJ (Hrsg) Vitiligo: a monograph on the basic and clinical science. Blackwell Science Ltd, Oxford, S 97\u2013100","DOI":"10.1002\/9780470760116.ch13"},{"key":"1915_CR49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(86)70160-6","volume":"15","author":"Porter","year":"1986","unstructured":"Porter J, Beuf A, Lerner A, Nordlund JJ (1986) The psychological effects of vitiligo: a comparison of vitiligo patients with normal controls, with psoriasis patients and with patients with other pigmentary disorders. J Am Acad Dermatol 15:220\u2013225","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","volume":"22","author":"Porter","year":"1990","unstructured":"Porter J, Beuf A, Lerner A, Nordlund JJ (1990) The effect of vitiligo on sexual relationships. J Am Acad Dermatol 22:221\u2013222","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-3083.2006.01378.x","volume":"20","author":"Pozo-Rom\u00e1n","year":"2006","unstructured":"Pozo-Rom\u00e1n T, Gonz\u00e1lez-L\u00f3pez A, Velasco-Vaquero ME, N\u00fa\u00f1ez-Cabez\u00f3n M (2006) Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience. J Eur Acad Dermatol Venereol 20:136\u2013142","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1915_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","volume":"6","author":"Rigopoulos","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A (2007) Hyperpigmentation and melasma. J Cosmet Dermatol 6:195\u2013202","journal-title":"J Cosmet Dermatol"},{"key":"1915_CR53","first-page":"1645","volume":"31","author":"Rokhsar","year":"2005","unstructured":"Rokhsar CK, Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 31:1645\u20131650","journal-title":"Dermatol Surg"},{"key":"1915_CR54","unstructured":"Salim A, Rengifo-Pardo M, Vincent S, Cuervo-Amore LG (2003) Melasma. In: Williams H, Bigby M, Diepgen T et al (Hrsg) Evidence-based dermatology, 2nd edn. BMJ Publishing Group, S 552\u2013567"},{"key":"1915_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","volume":"190","author":"Schallrueter","year":"1995","unstructured":"Schallrueter KU, Wood JM, Lemke KR et al (1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190:223\u2013229","journal-title":"Dermatology"},{"key":"1915_CR56","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.1989.tb00921.x","volume":"6","author":"Schulpi","year":"1989","unstructured":"Schulpi CH, Antoniu C, Michas T, Starigos J (1989) Phenylalanine plus ultraviolet light: preliminary reports of a promising treatment for childhood vitiligo. Pediatr Dermatol 6:332\u2013335","journal-title":"Pediatr Dermatol"},{"key":"1915_CR57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000247142","volume":"188","author":"Siddiqui","year":"1994","unstructured":"Siddiqui AH, Stolk LM, Bhaggoe R et al (1994) L-Phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 188:215\u2013218","journal-title":"Dermatology"},{"key":"1915_CR58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","volume":"51","author":"Silverberg","year":"2004","unstructured":"Silverberg NB, Lin P, Travis L et al (2004) Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 51:760\u2013766","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR59","first-page":"680","volume":"5","author":"Sivayathorn","year":"1995","unstructured":"Sivayathorn A, Verallo RV, Graupe K (1995) 20% azelaic acid cream in the topical treatment of melasma: a double-blind comparison with 2% hydroquinone. Eur J Dermatol 5:680\u2013684","journal-title":"Eur J Dermatol"},{"key":"1915_CR60","first-page":"237","volume":"72","author":"Souto","year":"1997","unstructured":"Souto MG, Manhaes AMH, Milhomens CH, Succi ICB (1997) Comparative study of melagenine and placebo for the treatment of vitiligo. An Bras Dermatol 72:237\u2013239","journal-title":"An Bras Dermatol"},{"key":"1915_CR61","first-page":"735","volume":"Opthalmol","author":"Spier","year":"1965","unstructured":"Spier F (1965) A case of irreversible steroid-induced rise in intraocular pressure. Acta Opthalmol (Copenhagen) 43:735\u2013745","journal-title":"Acta"},{"key":"1915_CR62","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0190-9622(94)70123-7","volume":"30","author":"Stern","year":"1994","unstructured":"Stern RS, Dover JS, Levin JA, Arndt KA (1994) Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol 30:985\u2013987","journal-title":"J Am Acad Dermatol"},{"key":"1915_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.1963.tb57113.x","volume":"100","author":"Stolar","year":"1963","unstructured":"Stolar R (1963) Induced alterations of vitiliginous skin. Ann NY Acad Sci 100:58\u201375","journal-title":"Ann NY Acad Sci"},{"key":"1915_CR64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14764170510037752","volume":"7","author":"Tannous","year":"2005","unstructured":"Tannous ZS, Astner S (2005) Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther 7:39\u201343","journal-title":"J Cosmet Laser Ther"},{"key":"1915_CR65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2230.2004.01462.x","volume":"29","author":"Valkova","year":"2004","unstructured":"Valkova S, Trashlieva M, Christova P (2004) Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol 29:180\u2013184","journal-title":"Clin Exp Dermatol"},{"key":"1915_CR66","first-page":"58","volume":"Suppl","author":"Verallo-Rowell","year":"1989","unstructured":"Verallo-Rowell VM, Verallo V, Graupe K et al (1989) Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 143:58\u201361","journal-title":"Acta Derm Venereol"},{"key":"1915_CR67","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","volume":"133","author":"Westerhof","year":"1997","unstructured":"Westerhof W, Nieuweboer-Krobotova L (1997) Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 133:1525\u20131528","journal-title":"Arch Dermatol"},{"key":"1915_CR68","doi-asserted-by":"crossref","unstructured":"Whitton ME, Pinart M, Batchelor J et al (2010) Interventions for vitiligo. Cochrane Database Syst Rev, Issue 1. Art. No.: CD003263. DOI: 10.1002\/14651858.CD003263.pub4","DOI":"10.1002\/14651858.CD003263.pub4"},{"key":"1915_CR69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","volume":"11","author":"Yokota","year":"1998","unstructured":"Yokota T, Nishio H, Kubota Y, Mizoguchi M (1998) The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11:355\u2013361","journal-title":"Pigment Cell Res"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-009-1915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1915-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:31:20Z","timestamp":1740177080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-009-1915-x"}},"subtitle":["Sinn oder Unsinn?","Sense or nonsense?"],"short-title":[],"issued":{"date-parts":[[2010,6,13]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s00105-009-1915-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"type":"print","value":"0017-8470"},{"type":"electronic","value":"1432-1173"}],"subject":[],"published":{"date-parts":[[2010,6,13]]}}}